The Association Between the Duration of Acute Kidney Injury and New-onset Chronic Kidney Disease After Cardiac or Thoracic Aortic Surgery

October 20, 2021 updated by: Seoul National University Hospital

The Association Between the Duration of Acute Kidney Injury and New-onset Chronic Kidney Disease After Cardiac or Thoracic Aortic Surgery: a Retrospective Observational Cohort Study

The investigators aimed to evaluate the association between the duration and stage of acute kidney injury (AKI) and the development of chronic kidney disease during postoperative three years in patients undergoing cardiac or thoracic aortic surgery.

Study Overview

Detailed Description

Postoperative acute kidney injury (AKI) has been investigated as an important contributor to postoperative morbidity and mortality after cardiovascular surgery. Also, temporary worsening of renal function after aortic surgery is associated with higher long-term mortality. Although the associations between AKI and chronic kidney disease (CKD) in medical or other surgical settings were reported, only a few studies evaluated this relationship in patients undergoing cardiac surgery. More specifically, the association of the severity or duration of AKI with the risk of the development of new-onset CKD after cardiac surgery has not been clearly elucidated.

It would be important to find predictors of the long-term renal function or risk factors for the development of CKD after cardiac surgery because postoperative management of high-risk patients to develop long-term renal dysfunction may prevent further deterioration in renal function and improve patient prognosis.

The investigators aimed to evaluate (1) the long-term renal function after cardiac surgery and (2) the association between the duration and stage of acute kidney injury (AKI) and the development of chronic kidney disease during postoperative three years in patients undergoing cardiac or thoracic aortic surgery.

Study Type

Observational

Enrollment (Actual)

2009

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A retrospective cohort of the adult patients who underwent cardiac or thoracic aortic surgery under cardiopulmonary bypass at Seoul National University Hospital between 2008 and 2017

Description

Inclusion Criteria:

  • Adult patients who underwent cardiac or thoracic aortic surgery under cardiopulmonary bypass at Seoul National University Hospital between 2008 and 2017

Exclusion Criteria:

  • Those with off-pump coronary artery bypass
  • Missing baseline serum creatinine
  • Missing postoperative serum creatinine values of more than three among seven postoperative days
  • Preoperative baseline chronic kidney disease with estimated glomerular filtration rate <60 ml/min/1.73m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
new-onset chronic kidney disease stage 3 or higher or mortality
Time Frame: during 3 years after surgery
development of new-onset chronic kidney disease stage 3 or higher or all-cause mortality developed during 3 years after surgery. The new-onset chronic kidney disease was defined by at least two estimated Glomerular Filtration Rate values <60 ml/min/1.73 m2 separated by an interval of at least three months.
during 3 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
new-onset chronic kidney disease stage 3 or higher or mortality
Time Frame: during 1 year after surgery
development of new-onset chronic kidney disease stage 3 or higher or all-cause mortality developed during 1 year after surgery
during 1 year after surgery
new-onset chronic kidney disease stage 3 or higher or mortality
Time Frame: during 2 years after surgery
development of new-onset chronic kidney disease stage 3 or higher or all-cause mortality developed during 2 years after surgery
during 2 years after surgery
Length of postoperative hospital stay
Time Frame: during one month after surgery
Length of postoperative hospital stay
during one month after surgery
Length of postoperative intensive care unit stay
Time Frame: during one month after surgery
Length of postoperative intensive care unit stay
during one month after surgery
intra-aortic balloon pulsation insertion
Time Frame: during surgery and postoperative one week
intra-aortic balloon pulsation insertion
during surgery and postoperative one week
Reopen for surgical bleeding
Time Frame: during one month after surgery
Reopen for surgical bleeding
during one month after surgery
Respiratory complication
Time Frame: during one month after surgery
a composite outcome including postoperative atelectasis, pneumonia, pulmonary edema, pleural effusion and pneumothorax
during one month after surgery
in-hospital mortality
Time Frame: during one month after surgery
all-cause mortality during hospital stay
during one month after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
Time Frame: at three months after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
at three months after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
Time Frame: at one year after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
at one year after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
Time Frame: at two years after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
at two years after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
Time Frame: at three years after surgery
Incidence of estimated Glomerular Filtration Rate <60 mL/min/1.73m2
at three years after surgery
Dependence on the regular hemodialysis
Time Frame: at three years after surgery
Dependence on the regular hemodialysis
at three years after surgery
estimated Glomerular Filtration Rate
Time Frame: at three months after surgery
estimated Glomerular Filtration Rate
at three months after surgery
estimated Glomerular Filtration Rate
Time Frame: at one year after surgery
estimated Glomerular Filtration Rate
at one year after surgery
estimated Glomerular Filtration Rate
Time Frame: at two years after surgery
estimated Glomerular Filtration Rate
at two years after surgery
estimated Glomerular Filtration Rate
Time Frame: at three years after surgery
estimated Glomerular Filtration Rate
at three years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Won Ho Kim, MD, PhD, Associate Professor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 19, 2019

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

November 19, 2019

First Submitted That Met QC Criteria

November 19, 2019

First Posted (Actual)

November 21, 2019

Study Record Updates

Last Update Posted (Actual)

October 22, 2021

Last Update Submitted That Met QC Criteria

October 20, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Kidney Injury

3
Subscribe